Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-04-19

FDA Approved: VALTREX — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for Valtrex (valacyclovir hydrochloride) submitted by GlaxoSmithKline LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALTREX (valacyclovir hydrochloride)

Snippet

SUPPL AP for VALTREX (VALACYCLOVIR HYDROCHLORIDE)